Rank | Gene Set | Z-score |
---|---|---|
1 | sarcomere organization (GO:0045214) | 8.66575465 |
2 | actin-myosin filament sliding (GO:0033275) | 8.41675680 |
3 | muscle filament sliding (GO:0030049) | 8.41675680 |
4 | cardiac myofibril assembly (GO:0055003) | 7.57192123 |
5 | myofibril assembly (GO:0030239) | 7.49482590 |
6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.33251238 |
7 | regulation of skeletal muscle contraction (GO:0014819) | 7.31287738 |
8 | plasma membrane repair (GO:0001778) | 7.08192984 |
9 | actin-mediated cell contraction (GO:0070252) | 6.92606070 |
10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.92450544 |
11 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.67898614 |
12 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.60237068 |
13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.45246369 |
14 | cardiac muscle contraction (GO:0060048) | 6.16588427 |
15 | tricarboxylic acid cycle (GO:0006099) | 6.05239444 |
16 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.89622457 |
17 | striated muscle contraction (GO:0006941) | 5.76659286 |
18 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.74994787 |
19 | regulation of relaxation of muscle (GO:1901077) | 5.64622466 |
20 | cardiac muscle cell development (GO:0055013) | 5.58770126 |
21 | actomyosin structure organization (GO:0031032) | 5.55880426 |
22 | skeletal muscle contraction (GO:0003009) | 5.55430485 |
23 | carnitine shuttle (GO:0006853) | 5.46527651 |
24 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.46028697 |
25 | regulation of actin filament-based movement (GO:1903115) | 5.40104322 |
26 | regulation of cell communication by electrical coupling (GO:0010649) | 5.31686195 |
27 | actin filament-based movement (GO:0030048) | 5.26664549 |
28 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.26572983 |
29 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.23874941 |
30 | cardiac cell development (GO:0055006) | 5.22819136 |
31 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.13734573 |
32 | adult heart development (GO:0007512) | 4.95870461 |
33 | regulation of sarcomere organization (GO:0060297) | 4.85559583 |
34 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.80086656 |
35 | regulation of membrane repolarization (GO:0060306) | 4.78555394 |
36 | cardiac muscle hypertrophy (GO:0003300) | 4.78515900 |
37 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.76673847 |
38 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.76384556 |
39 | fatty acid transmembrane transport (GO:1902001) | 4.65859207 |
40 | striated muscle hypertrophy (GO:0014897) | 4.64633211 |
41 | regulation of striated muscle contraction (GO:0006942) | 4.63373321 |
42 | neuron cell-cell adhesion (GO:0007158) | 4.54934867 |
43 | creatine metabolic process (GO:0006600) | 4.52726011 |
44 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.51255113 |
45 | heart trabecula formation (GO:0060347) | 4.47598216 |
46 | heart contraction (GO:0060047) | 4.45428617 |
47 | heart process (GO:0003015) | 4.45428617 |
48 | muscle tissue morphogenesis (GO:0060415) | 4.43012844 |
49 | regulation of timing of cell differentiation (GO:0048505) | 4.37443849 |
50 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.37278562 |
51 | regulation of coenzyme metabolic process (GO:0051196) | 4.32234808 |
52 | regulation of cofactor metabolic process (GO:0051193) | 4.32234808 |
53 | skeletal muscle adaptation (GO:0043501) | 4.19370695 |
54 | regulation of development, heterochronic (GO:0040034) | 4.15117338 |
55 | muscle contraction (GO:0006936) | 4.14208058 |
56 | presynaptic membrane organization (GO:0097090) | 4.13935812 |
57 | muscle hypertrophy (GO:0014896) | 4.06314178 |
58 | postsynaptic membrane organization (GO:0001941) | 4.06273230 |
59 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.05222590 |
60 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.05222590 |
61 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.04009897 |
62 | auditory behavior (GO:0031223) | 3.99257849 |
63 | carnitine transmembrane transport (GO:1902603) | 3.98308803 |
64 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.94280846 |
65 | regulation of the force of heart contraction (GO:0002026) | 3.94033156 |
66 | cell communication involved in cardiac conduction (GO:0086065) | 3.93818941 |
67 | response to inactivity (GO:0014854) | 3.90825336 |
68 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.89390685 |
69 | striatum development (GO:0021756) | 3.88865768 |
70 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.86896254 |
71 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.85216134 |
72 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.84427247 |
73 | muscle system process (GO:0003012) | 3.81112859 |
74 | cardiac muscle cell action potential (GO:0086001) | 3.80378765 |
75 | ATP synthesis coupled proton transport (GO:0015986) | 3.78805923 |
76 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.78805923 |
77 | NADH metabolic process (GO:0006734) | 3.77006646 |
78 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.74641389 |
79 | transmission of nerve impulse (GO:0019226) | 3.74087039 |
80 | 2-oxoglutarate metabolic process (GO:0006103) | 3.71916638 |
81 | respiratory electron transport chain (GO:0022904) | 3.71518866 |
82 | protein localization to synapse (GO:0035418) | 3.70353729 |
83 | mechanosensory behavior (GO:0007638) | 3.70256016 |
84 | striated muscle adaptation (GO:0014888) | 3.69787569 |
85 | negative regulation of potassium ion transport (GO:0043267) | 3.68948836 |
86 | presynaptic membrane assembly (GO:0097105) | 3.68087661 |
87 | striated muscle cell development (GO:0055002) | 3.67985614 |
88 | positive regulation of cation channel activity (GO:2001259) | 3.67608664 |
89 | regulation of sulfur metabolic process (GO:0042762) | 3.66665940 |
90 | otic vesicle formation (GO:0030916) | 3.65593598 |
91 | vocalization behavior (GO:0071625) | 3.64819657 |
92 | oxidative phosphorylation (GO:0006119) | 3.64782054 |
93 | regulation of heart rate (GO:0002027) | 3.63907589 |
94 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.63486295 |
95 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.63486295 |
96 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.63285958 |
97 | muscle hypertrophy in response to stress (GO:0003299) | 3.63285958 |
98 | cardiac muscle adaptation (GO:0014887) | 3.63285958 |
99 | carnitine transport (GO:0015879) | 3.62806524 |
100 | amino-acid betaine transport (GO:0015838) | 3.62806524 |
101 | regulation of sequestering of triglyceride (GO:0010889) | 3.61292613 |
102 | electron transport chain (GO:0022900) | 3.60907702 |
103 | glycogen catabolic process (GO:0005980) | 3.60666949 |
104 | regulation of cardiac muscle contraction (GO:0055117) | 3.54081996 |
105 | negative regulation of protein localization to cell surface (GO:2000009) | 3.49314909 |
106 | regulation of ATPase activity (GO:0043462) | 3.46709113 |
107 | regulation of ATP catabolic process (GO:1903289) | 3.46709113 |
108 | cytidine catabolic process (GO:0006216) | 3.46564491 |
109 | cytidine deamination (GO:0009972) | 3.46564491 |
110 | cytidine metabolic process (GO:0046087) | 3.46564491 |
111 | neuron fate determination (GO:0048664) | 3.46482853 |
112 | response to muscle activity (GO:0014850) | 3.46250579 |
113 | cardiac conduction (GO:0061337) | 3.44261431 |
114 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.39086327 |
115 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.37912547 |
116 | positive regulation of heart rate (GO:0010460) | 3.37857238 |
117 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.36396050 |
118 | glucan catabolic process (GO:0009251) | 3.35595925 |
119 | cerebellar granule cell differentiation (GO:0021707) | 3.32401088 |
120 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.32050870 |
121 | adult walking behavior (GO:0007628) | 3.30683249 |
122 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.27818772 |
123 | dendritic spine morphogenesis (GO:0060997) | 3.21973860 |
124 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.16568301 |
125 | layer formation in cerebral cortex (GO:0021819) | 3.12244208 |
126 | neuron recognition (GO:0008038) | 3.11035093 |
127 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.10225382 |
128 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.09054848 |
129 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.09054848 |
130 | synapse assembly (GO:0007416) | 3.06365959 |
131 | central nervous system neuron axonogenesis (GO:0021955) | 3.05695246 |
132 | synaptic vesicle maturation (GO:0016188) | 3.04338874 |
133 | heart valve formation (GO:0003188) | 2.99628105 |
134 | behavioral response to cocaine (GO:0048148) | 2.96573429 |
135 | limb bud formation (GO:0060174) | 2.92683992 |
136 | cell proliferation in forebrain (GO:0021846) | 2.88172347 |
137 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.87448975 |
138 | regulation of synapse structural plasticity (GO:0051823) | 2.85575198 |
139 | inner ear receptor stereocilium organization (GO:0060122) | 2.85267582 |
140 | positive regulation of potassium ion transport (GO:0043268) | 2.80946894 |
141 | positive regulation of synapse assembly (GO:0051965) | 2.79406981 |
142 | peristalsis (GO:0030432) | 2.79134718 |
143 | proline transport (GO:0015824) | 2.77359863 |
144 | synaptic vesicle endocytosis (GO:0048488) | 2.77281981 |
145 | positive regulation of mitochondrial fission (GO:0090141) | 2.73801817 |
146 | retinal ganglion cell axon guidance (GO:0031290) | 2.71241728 |
147 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.71106631 |
148 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.71105688 |
149 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.70757752 |
150 | regulation of cilium movement (GO:0003352) | 2.68244292 |
151 | axoneme assembly (GO:0035082) | 2.66251948 |
152 | long term synaptic depression (GO:0060292) | 2.64767871 |
153 | phosphorelay signal transduction system (GO:0000160) | 2.63740923 |
154 | glycosphingolipid biosynthetic process (GO:0006688) | 2.63110917 |
155 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.62582493 |
156 | cerebral cortex cell migration (GO:0021795) | 2.61242890 |
157 | cerebral cortex neuron differentiation (GO:0021895) | 2.60671848 |
158 | protein polyglutamylation (GO:0018095) | 2.59313397 |
159 | cochlea development (GO:0090102) | 2.58195617 |
160 | establishment of nucleus localization (GO:0040023) | 2.57918996 |
161 | ephrin receptor signaling pathway (GO:0048013) | 2.56771809 |
162 | retinal cone cell development (GO:0046549) | 2.56136319 |
163 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.55823881 |
164 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.55199512 |
165 | regulation of synapse assembly (GO:0051963) | 2.54187615 |
166 | asymmetric protein localization (GO:0008105) | 2.52770983 |
167 | response to auditory stimulus (GO:0010996) | 2.52769402 |
168 | auditory receptor cell stereocilium organization (GO:0060088) | 2.52293104 |
169 | nucleobase catabolic process (GO:0046113) | 2.51140803 |
170 | neuron-neuron synaptic transmission (GO:0007270) | 2.47257473 |
171 | regulation of microtubule-based movement (GO:0060632) | 2.46310558 |
172 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.45986495 |
173 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.45986495 |
174 | dentate gyrus development (GO:0021542) | 2.45869947 |
175 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.45571135 |
176 | axonal fasciculation (GO:0007413) | 2.44123558 |
177 | telencephalon cell migration (GO:0022029) | 2.43123754 |
178 | oligodendrocyte differentiation (GO:0048709) | 2.42734171 |
179 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.40913886 |
180 | Golgi to endosome transport (GO:0006895) | 2.40449696 |
181 | dopamine transport (GO:0015872) | 2.40203503 |
182 | neuronal action potential propagation (GO:0019227) | 2.39934995 |
183 | cAMP catabolic process (GO:0006198) | 2.39253805 |
184 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.39137602 |
185 | neurotransmitter secretion (GO:0007269) | 2.38427454 |
186 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.38176176 |
187 | forebrain cell migration (GO:0021885) | 2.36331048 |
188 | synaptic vesicle exocytosis (GO:0016079) | 2.36263723 |
189 | glutamate secretion (GO:0014047) | 2.36139566 |
190 | synapse organization (GO:0050808) | 2.35903282 |
191 | synaptic transmission, dopaminergic (GO:0001963) | 2.35268187 |
192 | sex differentiation (GO:0007548) | 2.34855701 |
193 | neuromuscular synaptic transmission (GO:0007274) | 2.34777761 |
194 | establishment of protein localization to Golgi (GO:0072600) | 2.34514485 |
195 | neuronal action potential (GO:0019228) | 2.33978700 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.08594255 |
2 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.16897298 |
3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.87806970 |
4 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.63476322 |
5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.63476322 |
6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.55654833 |
7 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.35456827 |
8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.12692406 |
9 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.99564510 |
10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.95487694 |
11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.94938566 |
12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.90366772 |
13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.80524671 |
14 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.76797069 |
15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.67639860 |
16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.66668719 |
17 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.62538843 |
18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.54993709 |
19 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.52396992 |
20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.46230950 |
21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.42992006 |
22 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.40590528 |
23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.40002962 |
24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.30979166 |
25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.19730626 |
26 | VDR_22108803_ChIP-Seq_LS180_Human | 2.18566740 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.12746128 |
28 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.03537090 |
29 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.00389829 |
30 | FUS_26573619_Chip-Seq_HEK293_Human | 1.97861700 |
31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.96223509 |
32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.95523430 |
33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.94614846 |
34 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.94174500 |
35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.92039138 |
36 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.86911356 |
37 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.86558761 |
38 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.84342577 |
39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.79613196 |
40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.78508658 |
41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.75449217 |
42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.70242372 |
43 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.70028780 |
44 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.67837965 |
45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67133580 |
46 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65278640 |
47 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.64199667 |
48 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.64199667 |
49 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63849937 |
50 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.63674624 |
51 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.63217642 |
52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.63046740 |
53 | STAT3_23295773_ChIP-Seq_U87_Human | 1.62345730 |
54 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.61919393 |
55 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.61524937 |
56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60341695 |
57 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.60339304 |
58 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.58431822 |
59 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.56067749 |
60 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.54874045 |
61 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.54136108 |
62 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.53172698 |
63 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.51597065 |
64 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.51433102 |
65 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48839130 |
66 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47619940 |
67 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46872220 |
68 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.46489912 |
69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45003599 |
70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.44886976 |
71 | TCF4_23295773_ChIP-Seq_U87_Human | 1.44667294 |
72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44276869 |
73 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.42254860 |
74 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.42025431 |
75 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.40183034 |
76 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.40011055 |
77 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.39754941 |
78 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.39125483 |
79 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37591802 |
80 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.37296012 |
81 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.36284434 |
82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.36027760 |
83 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.36027760 |
84 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.35186357 |
85 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.34846207 |
86 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34545406 |
87 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.33890724 |
88 | EWS_26573619_Chip-Seq_HEK293_Human | 1.32411776 |
89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31099571 |
90 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.30888137 |
91 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.29884543 |
92 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.28622389 |
93 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.27857820 |
94 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27694947 |
95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.26524496 |
96 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25921926 |
97 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24813260 |
98 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.24734916 |
99 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.24674073 |
100 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.21791646 |
101 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21611112 |
102 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21186370 |
103 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.20867453 |
104 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20168568 |
105 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19553938 |
106 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19460834 |
107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18321698 |
108 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.17806634 |
109 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.17527166 |
110 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16390840 |
111 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.16315328 |
112 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14951523 |
113 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13963007 |
114 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13321252 |
115 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12514891 |
116 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12325059 |
117 | AR_19668381_ChIP-Seq_PC3_Human | 1.12304384 |
118 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.12236436 |
119 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.12098666 |
120 | KDM2B_26808549_Chip-Seq_REH_Human | 1.11714817 |
121 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11682068 |
122 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.11128283 |
123 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.10739868 |
124 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10213786 |
125 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09697084 |
126 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09217194 |
127 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07386033 |
128 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.07000783 |
129 | P68_20966046_ChIP-Seq_HELA_Human | 1.06330454 |
130 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06270515 |
131 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05621760 |
132 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.05528558 |
133 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.05029281 |
134 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.04950243 |
135 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.04857100 |
136 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.04755544 |
137 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04748274 |
138 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.02799754 |
139 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.02620553 |
140 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02453557 |
141 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.02393164 |
142 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.02213018 |
143 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02035194 |
144 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01507580 |
145 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.00045400 |
146 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98337242 |
147 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.98097426 |
148 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97658771 |
149 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96562732 |
150 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95789522 |
151 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95527144 |
152 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95132129 |
153 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.94252128 |
154 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93125947 |
155 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91254254 |
156 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.91050095 |
157 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90813951 |
158 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.89224465 |
159 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87759192 |
160 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87533256 |
161 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.87433622 |
162 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87221434 |
163 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86946127 |
164 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.85961320 |
165 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.84944868 |
166 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.84090249 |
167 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.84090249 |
168 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84055469 |
169 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.83916452 |
170 | ATF3_27146783_Chip-Seq_COLON_Human | 0.83903761 |
171 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83052312 |
172 | KDM2B_26808549_Chip-Seq_K562_Human | 0.82832580 |
173 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.82793919 |
174 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.82646847 |
175 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.82466410 |
176 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.81920767 |
177 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81031654 |
178 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80116816 |
179 | SA1_27219007_Chip-Seq_Bcells_Human | 0.79855272 |
180 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79791582 |
181 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79700036 |
182 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.78761734 |
183 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.76537187 |
184 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.76469175 |
185 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.76342305 |
186 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.75811398 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 6.47400054 |
2 | MP0003646_muscle_fatigue | 6.38593190 |
3 | MP0003880_abnormal_central_pattern | 6.12248420 |
4 | MP0000751_myopathy | 5.66991508 |
5 | MP0004084_abnormal_cardiac_muscle | 4.82840562 |
6 | MP0000749_muscle_degeneration | 4.70119809 |
7 | MP0004036_abnormal_muscle_relaxation | 4.33319551 |
8 | * MP0004215_abnormal_myocardial_fiber | 3.89812210 |
9 | MP0004145_abnormal_muscle_electrophysio | 3.81167347 |
10 | MP0005330_cardiomyopathy | 3.52856148 |
11 | MP0004087_abnormal_muscle_fiber | 3.24872439 |
12 | MP0002106_abnormal_muscle_physiology | 3.05664933 |
13 | MP0000750_abnormal_muscle_regeneration | 2.97089190 |
14 | MP0004859_abnormal_synaptic_plasticity | 2.94190934 |
15 | MP0005620_abnormal_muscle_contractility | 2.87992171 |
16 | MP0002269_muscular_atrophy | 2.78896645 |
17 | MP0002972_abnormal_cardiac_muscle | 2.78453163 |
18 | MP0004130_abnormal_muscle_cell | 2.75577344 |
19 | MP0000747_muscle_weakness | 2.75473273 |
20 | MP0003136_yellow_coat_color | 2.75010614 |
21 | MP0000778_abnormal_nervous_system | 2.68247040 |
22 | MP0003137_abnormal_impulse_conducting | 2.54775310 |
23 | MP0000759_abnormal_skeletal_muscle | 2.53394805 |
24 | MP0005369_muscle_phenotype | 2.52656483 |
25 | MP0008775_abnormal_heart_ventricle | 2.46656452 |
26 | MP0004484_altered_response_of | 2.37229895 |
27 | MP0010630_abnormal_cardiac_muscle | 2.26863743 |
28 | MP0001544_abnormal_cardiovascular_syste | 2.24314848 |
29 | MP0005385_cardiovascular_system_phenoty | 2.24314848 |
30 | MP0004233_abnormal_muscle_weight | 2.20480074 |
31 | MP0003890_abnormal_embryonic-extraembry | 2.10005950 |
32 | MP0003635_abnormal_synaptic_transmissio | 2.02950841 |
33 | MP0001984_abnormal_olfaction | 1.96080800 |
34 | MP0008877_abnormal_DNA_methylation | 1.94321113 |
35 | MP0006138_congestive_heart_failure | 1.94166017 |
36 | MP0001529_abnormal_vocalization | 1.93660142 |
37 | MP0001486_abnormal_startle_reflex | 1.92188833 |
38 | MP0002064_seizures | 1.90971951 |
39 | MP0004085_abnormal_heartbeat | 1.80114191 |
40 | MP0006036_abnormal_mitochondrial_physio | 1.79804577 |
41 | MP0003221_abnormal_cardiomyocyte_apopto | 1.79213306 |
42 | MP0002638_abnormal_pupillary_reflex | 1.75837980 |
43 | MP0002102_abnormal_ear_morphology | 1.73595499 |
44 | MP0005551_abnormal_eye_electrophysiolog | 1.72895749 |
45 | MP0006276_abnormal_autonomic_nervous | 1.71989655 |
46 | MP0005394_taste/olfaction_phenotype | 1.70112107 |
47 | MP0005499_abnormal_olfactory_system | 1.70112107 |
48 | MP0003828_pulmonary_edema | 1.69291757 |
49 | MP0002332_abnormal_exercise_endurance | 1.63305446 |
50 | MP0009745_abnormal_behavioral_response | 1.57192720 |
51 | MP0002272_abnormal_nervous_system | 1.56734535 |
52 | MP0002063_abnormal_learning/memory/cond | 1.55676125 |
53 | MP0009046_muscle_twitch | 1.55445429 |
54 | * MP0002572_abnormal_emotion/affect_behav | 1.52877642 |
55 | MP0001501_abnormal_sleep_pattern | 1.51557060 |
56 | MP0002735_abnormal_chemical_nociception | 1.49100664 |
57 | MP0005423_abnormal_somatic_nervous | 1.47757617 |
58 | MP0001968_abnormal_touch/_nociception | 1.45162273 |
59 | MP0005084_abnormal_gallbladder_morpholo | 1.44495221 |
60 | MP0002127_abnormal_cardiovascular_syste | 1.40239954 |
61 | MP0008789_abnormal_olfactory_epithelium | 1.35665304 |
62 | MP0002734_abnormal_mechanical_nocicepti | 1.35402609 |
63 | MP0004510_myositis | 1.34933730 |
64 | MP0001485_abnormal_pinna_reflex | 1.32823080 |
65 | MP0005253_abnormal_eye_physiology | 1.32607091 |
66 | MP0000955_abnormal_spinal_cord | 1.31960144 |
67 | MP0002928_abnormal_bile_duct | 1.31740226 |
68 | MP0006292_abnormal_olfactory_placode | 1.29614149 |
69 | MP0000631_abnormal_neuroendocrine_gland | 1.28722634 |
70 | MP0002067_abnormal_sensory_capabilities | 1.28240238 |
71 | MP0002736_abnormal_nociception_after | 1.27989068 |
72 | MP0000566_synostosis | 1.25047581 |
73 | MP0003950_abnormal_plasma_membrane | 1.23912361 |
74 | MP0002882_abnormal_neuron_morphology | 1.23891283 |
75 | MP0002108_abnormal_muscle_morphology | 1.23043452 |
76 | MP0002234_abnormal_pharynx_morphology | 1.20636484 |
77 | MP0004811_abnormal_neuron_physiology | 1.19542969 |
78 | MP0002653_abnormal_ependyma_morphology | 1.15598986 |
79 | * MP0005666_abnormal_adipose_tissue | 1.12854030 |
80 | MP0006072_abnormal_retinal_apoptosis | 1.11933943 |
81 | MP0004185_abnormal_adipocyte_glucose | 1.11169695 |
82 | MP0000427_abnormal_hair_cycle | 1.08937242 |
83 | MP0000343_altered_response_to | 1.08687164 |
84 | MP0000383_abnormal_hair_follicle | 1.08288883 |
85 | MP0002233_abnormal_nose_morphology | 1.07773419 |
86 | MP0000013_abnormal_adipose_tissue | 1.07369443 |
87 | MP0001970_abnormal_pain_threshold | 1.07264569 |
88 | MP0001502_abnormal_circadian_rhythm | 1.06474426 |
89 | MP0002733_abnormal_thermal_nociception | 1.05906016 |
90 | * MP0002557_abnormal_social/conspecific_i | 1.04969432 |
91 | MP0000733_abnormal_muscle_development | 1.03314389 |
92 | MP0002184_abnormal_innervation | 1.02175769 |
93 | MP0002752_abnormal_somatic_nervous | 1.01915695 |
94 | MP0005670_abnormal_white_adipose | 0.99365136 |
95 | MP0003567_abnormal_fetal_cardiomyocyte | 0.99200731 |
96 | MP0002152_abnormal_brain_morphology | 0.97905833 |
97 | MP0000266_abnormal_heart_morphology | 0.97680278 |
98 | MP0004885_abnormal_endolymph | 0.97473478 |
99 | MP0005165_increased_susceptibility_to | 0.96832064 |
100 | MP0006035_abnormal_mitochondrial_morpho | 0.96046602 |
101 | MP0005266_abnormal_metabolism | 0.93125808 |
102 | MP0004133_heterotaxia | 0.91842360 |
103 | * MP0005375_adipose_tissue_phenotype | 0.91096895 |
104 | MP0003121_genomic_imprinting | 0.90074798 |
105 | MP0002909_abnormal_adrenal_gland | 0.89240797 |
106 | MP0003861_abnormal_nervous_system | 0.89214787 |
107 | * MP0002066_abnormal_motor_capabilities/c | 0.88378902 |
108 | MP0003119_abnormal_digestive_system | 0.87455740 |
109 | MP0000026_abnormal_inner_ear | 0.85968938 |
110 | MP0000049_abnormal_middle_ear | 0.85108537 |
111 | MP0003183_abnormal_peptide_metabolism | 0.84959152 |
112 | MP0003122_maternal_imprinting | 0.83610510 |
113 | MP0005646_abnormal_pituitary_gland | 0.82114373 |
114 | MP0008872_abnormal_physiological_respon | 0.81154619 |
115 | MP0003633_abnormal_nervous_system | 0.80425763 |
116 | MP0004043_abnormal_pH_regulation | 0.78895724 |
117 | MP0000003_abnormal_adipose_tissue | 0.78597753 |
118 | MP0003279_aneurysm | 0.78581982 |
119 | MP0003787_abnormal_imprinting | 0.77349917 |
120 | MP0005391_vision/eye_phenotype | 0.77179067 |
121 | MP0003698_abnormal_male_reproductive | 0.75427764 |
122 | MP0010368_abnormal_lymphatic_system | 0.75414577 |
123 | MP0002229_neurodegeneration | 0.74726265 |
124 | MP0008995_early_reproductive_senescence | 0.74072035 |
125 | MP0003806_abnormal_nucleotide_metabolis | 0.72877758 |
126 | MP0005195_abnormal_posterior_eye | 0.72746759 |
127 | * MP0002971_abnormal_brown_adipose | 0.72666570 |
128 | MP0000428_abnormal_craniofacial_morphol | 0.72382086 |
129 | MP0001177_atelectasis | 0.71769669 |
130 | MP0003937_abnormal_limbs/digits/tail_de | 0.70539625 |
131 | MP0003011_delayed_dark_adaptation | 0.70421371 |
132 | MP0004742_abnormal_vestibular_system | 0.70349654 |
133 | * MP0000230_abnormal_systemic_arterial | 0.63387521 |
134 | MP0002128_abnormal_blood_circulation | 0.63251773 |
135 | MP0008961_abnormal_basal_metabolism | 0.62275226 |
136 | MP0008004_abnormal_stomach_pH | 0.60750310 |
137 | * MP0002078_abnormal_glucose_homeostasis | 0.60317231 |
138 | MP0003705_abnormal_hypodermis_morpholog | 0.58646057 |
139 | MP0009780_abnormal_chondrocyte_physiolo | 0.54554557 |
140 | MP0005187_abnormal_penis_morphology | 0.49221443 |
141 | MP0005319_abnormal_enzyme/_coenzyme | 0.47453092 |
142 | MP0003566_abnormal_cell_adhesion | 0.46644027 |
143 | MP0005535_abnormal_body_temperature | 0.44913785 |
144 | MP0004147_increased_porphyrin_level | 0.43975759 |
145 | MP0005623_abnormal_meninges_morphology | 0.43508068 |
146 | MP0003045_fibrosis | 0.42603901 |
147 | MP0005275_abnormal_skin_tensile | 0.42131131 |
148 | MP0005451_abnormal_body_composition | 0.40942807 |
149 | MP0005334_abnormal_fat_pad | 0.39508488 |
150 | MP0000767_abnormal_smooth_muscle | 0.36099810 |
151 | MP0001879_abnormal_lymphatic_vessel | 0.34229593 |
152 | MP0004270_analgesia | 0.34144136 |
153 | MP0000579_abnormal_nail_morphology | 0.34100652 |
154 | MP0003948_abnormal_gas_homeostasis | 0.33170084 |
155 | MP0005083_abnormal_biliary_tract | 0.33116642 |
156 | MP0003283_abnormal_digestive_organ | 0.32889500 |
157 | MP0004272_abnormal_basement_membrane | 0.32646537 |
158 | MP0001299_abnormal_eye_distance/ | 0.29775882 |
159 | MP0002877_abnormal_melanocyte_morpholog | 0.29432500 |
160 | MP0002822_catalepsy | 0.28630452 |
161 | * MP0002925_abnormal_cardiovascular_devel | 0.28386806 |
162 | MP0003195_calcinosis | 0.27107392 |
163 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.26967950 |
164 | MP0004924_abnormal_behavior | 0.26781582 |
165 | MP0005386_behavior/neurological_phenoty | 0.26781582 |
166 | MP0008569_lethality_at_weaning | 0.26498732 |
167 | * MP0002118_abnormal_lipid_homeostasis | 0.25215599 |
168 | * MP0005452_abnormal_adipose_tissue | 0.24197867 |
169 | MP0009115_abnormal_fat_cell | 0.23898553 |
170 | MP0008438_abnormal_cutaneous_collagen | 0.23407423 |
171 | MP0008874_decreased_physiological_sensi | 0.23167813 |
172 | MP0001784_abnormal_fluid_regulation | 0.22350046 |
173 | MP0001765_abnormal_ion_homeostasis | 0.20613282 |
174 | MP0001727_abnormal_embryo_implantation | 0.20297570 |
175 | * MP0001614_abnormal_blood_vessel | 0.18912083 |
176 | MP0005376_homeostasis/metabolism_phenot | 0.18666116 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Exercise-induced myalgia (HP:0003738) | 7.16332078 |
2 | Calf muscle hypertrophy (HP:0008981) | 6.87130824 |
3 | Exercise-induced muscle cramps (HP:0003710) | 6.82875492 |
4 | Sudden death (HP:0001699) | 6.76336264 |
5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.74158412 |
6 | Muscle fiber splitting (HP:0003555) | 5.91555228 |
7 | Muscle fiber inclusion bodies (HP:0100299) | 5.65479127 |
8 | Ventricular tachycardia (HP:0004756) | 5.63770293 |
9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.33735965 |
10 | Hyporeflexia of lower limbs (HP:0002600) | 5.31942164 |
11 | Myoglobinuria (HP:0002913) | 5.31929525 |
12 | Abnormality of the calf musculature (HP:0001430) | 5.27020742 |
13 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.90888199 |
14 | Subaortic stenosis (HP:0001682) | 4.90888199 |
15 | Atrial fibrillation (HP:0005110) | 4.75072874 |
16 | Type 1 muscle fiber predominance (HP:0003803) | 4.74672862 |
17 | Nemaline bodies (HP:0003798) | 4.73795972 |
18 | EMG: myopathic abnormalities (HP:0003458) | 4.68482963 |
19 | Increased connective tissue (HP:0009025) | 4.55481233 |
20 | Difficulty running (HP:0009046) | 4.49983586 |
21 | Primary atrial arrhythmia (HP:0001692) | 4.44286075 |
22 | Supraventricular tachycardia (HP:0004755) | 4.29163510 |
23 | Lipoatrophy (HP:0100578) | 4.24373477 |
24 | Supraventricular arrhythmia (HP:0005115) | 4.19863824 |
25 | Rhabdomyolysis (HP:0003201) | 4.12142473 |
26 | Asymmetric septal hypertrophy (HP:0001670) | 4.02199653 |
27 | Bundle branch block (HP:0011710) | 3.97880118 |
28 | Myotonia (HP:0002486) | 3.94195161 |
29 | Right ventricular cardiomyopathy (HP:0011663) | 3.85022674 |
30 | Syncope (HP:0001279) | 3.84542945 |
31 | Prolonged QT interval (HP:0001657) | 3.79303910 |
32 | Dilated cardiomyopathy (HP:0001644) | 3.73319791 |
33 | Palpitations (HP:0001962) | 3.65607824 |
34 | Oligodactyly (hands) (HP:0001180) | 3.61687422 |
35 | Muscle stiffness (HP:0003552) | 3.48358772 |
36 | Ventricular arrhythmia (HP:0004308) | 3.40232858 |
37 | Difficulty climbing stairs (HP:0003551) | 3.31606984 |
38 | Ventricular fibrillation (HP:0001663) | 3.31066977 |
39 | Heart block (HP:0012722) | 3.25566508 |
40 | Distal arthrogryposis (HP:0005684) | 3.23960244 |
41 | Myopathic facies (HP:0002058) | 3.19647492 |
42 | Drooling (HP:0002307) | 3.13326064 |
43 | Split foot (HP:0001839) | 3.13076414 |
44 | Hypoplastic iliac wings (HP:0002866) | 3.12733373 |
45 | Hypoplastic nipples (HP:0002557) | 3.08780903 |
46 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.07546540 |
47 | Abnormal atrioventricular conduction (HP:0005150) | 3.07058508 |
48 | Increased variability in muscle fiber diameter (HP:0003557) | 3.06243646 |
49 | Distal lower limb muscle weakness (HP:0009053) | 3.02188082 |
50 | Neck muscle weakness (HP:0000467) | 2.99491938 |
51 | Abnormality of the lower motor neuron (HP:0002366) | 2.98857416 |
52 | True hermaphroditism (HP:0010459) | 2.97722104 |
53 | Areflexia of lower limbs (HP:0002522) | 2.96025689 |
54 | Atrioventricular block (HP:0001678) | 2.94693815 |
55 | Hyperventilation (HP:0002883) | 2.89714627 |
56 | Abnormality of the labia minora (HP:0012880) | 2.88782286 |
57 | Rimmed vacuoles (HP:0003805) | 2.83091606 |
58 | Excessive salivation (HP:0003781) | 2.82716537 |
59 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.77104294 |
60 | Round ear (HP:0100830) | 2.75629951 |
61 | Abnormal EKG (HP:0003115) | 2.73697196 |
62 | Oligodactyly (HP:0012165) | 2.65214730 |
63 | Epileptic encephalopathy (HP:0200134) | 2.64519543 |
64 | Ketoacidosis (HP:0001993) | 2.64478629 |
65 | Atonic seizures (HP:0010819) | 2.62030049 |
66 | Febrile seizures (HP:0002373) | 2.59747403 |
67 | Broad-based gait (HP:0002136) | 2.58604631 |
68 | Limb-girdle muscle atrophy (HP:0003797) | 2.57780054 |
69 | Left ventricular hypertrophy (HP:0001712) | 2.54496729 |
70 | Focal motor seizures (HP:0011153) | 2.50464157 |
71 | Focal seizures (HP:0007359) | 2.50308105 |
72 | Progressive cerebellar ataxia (HP:0002073) | 2.47391572 |
73 | Ulnar deviation of the wrist (HP:0003049) | 2.46956020 |
74 | Morphological abnormality of the inner ear (HP:0011390) | 2.45681769 |
75 | Limb dystonia (HP:0002451) | 2.44305033 |
76 | Gait imbalance (HP:0002141) | 2.42481254 |
77 | Myokymia (HP:0002411) | 2.41500761 |
78 | Volvulus (HP:0002580) | 2.41092673 |
79 | EMG: neuropathic changes (HP:0003445) | 2.39909736 |
80 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.39586648 |
81 | Poor eye contact (HP:0000817) | 2.38101424 |
82 | Hypoglycemic coma (HP:0001325) | 2.37053392 |
83 | Hepatic necrosis (HP:0002605) | 2.36363290 |
84 | Specific learning disability (HP:0001328) | 2.35469050 |
85 | Acute necrotizing encephalopathy (HP:0006965) | 2.35453218 |
86 | Congenital stationary night blindness (HP:0007642) | 2.34178162 |
87 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.32448221 |
88 | Fibular aplasia (HP:0002990) | 2.30657174 |
89 | Nephrogenic diabetes insipidus (HP:0009806) | 2.30246852 |
90 | Synostosis involving the elbow (HP:0003938) | 2.29781406 |
91 | Humeroradial synostosis (HP:0003041) | 2.29781406 |
92 | Amyotrophic lateral sclerosis (HP:0007354) | 2.28262341 |
93 | Hypoplastic pelvis (HP:0008839) | 2.27367418 |
94 | Testicular atrophy (HP:0000029) | 2.27262648 |
95 | Hypoplastic ischia (HP:0003175) | 2.26776842 |
96 | Pancreatic cysts (HP:0001737) | 2.26608168 |
97 | Action tremor (HP:0002345) | 2.24962078 |
98 | Abnormality of cochlea (HP:0000375) | 2.23900236 |
99 | Spastic gait (HP:0002064) | 2.22269488 |
100 | Facial diplegia (HP:0001349) | 2.20398735 |
101 | Frequent falls (HP:0002359) | 2.20286012 |
102 | Muscular dystrophy (HP:0003560) | 2.20002901 |
103 | Pancreatic fibrosis (HP:0100732) | 2.19597972 |
104 | Absent speech (HP:0001344) | 2.18241983 |
105 | Congenital primary aphakia (HP:0007707) | 2.18210923 |
106 | Distal lower limb amyotrophy (HP:0008944) | 2.18064386 |
107 | Genital tract atresia (HP:0001827) | 2.16373615 |
108 | Abnormal hair whorl (HP:0010721) | 2.15126316 |
109 | Proximal amyotrophy (HP:0007126) | 2.15013257 |
110 | Ankle clonus (HP:0011448) | 2.13814650 |
111 | Impaired social interactions (HP:0000735) | 2.13368889 |
112 | Abnormal social behavior (HP:0012433) | 2.13368889 |
113 | Gowers sign (HP:0003391) | 2.13072578 |
114 | Generalized muscle weakness (HP:0003324) | 2.12945261 |
115 | Palmoplantar keratoderma (HP:0000982) | 2.12922852 |
116 | Lissencephaly (HP:0001339) | 2.11800987 |
117 | Increased muscle lipid content (HP:0009058) | 2.10928259 |
118 | Progressive muscle weakness (HP:0003323) | 2.08952235 |
119 | Molar tooth sign on MRI (HP:0002419) | 2.08275355 |
120 | Abnormality of midbrain morphology (HP:0002418) | 2.08275355 |
121 | Scapular winging (HP:0003691) | 2.06492372 |
122 | Vaginal atresia (HP:0000148) | 2.05438172 |
123 | Broad alveolar ridges (HP:0000187) | 2.05263173 |
124 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.04693890 |
125 | Long clavicles (HP:0000890) | 2.04688257 |
126 | Nephronophthisis (HP:0000090) | 2.03814659 |
127 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03024573 |
128 | Hepatocellular necrosis (HP:0001404) | 2.00749234 |
129 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.00637763 |
130 | Acute encephalopathy (HP:0006846) | 2.00583274 |
131 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.00461169 |
132 | Retinal dysplasia (HP:0007973) | 2.00335212 |
133 | Medial flaring of the eyebrow (HP:0010747) | 1.99491652 |
134 | Protruding tongue (HP:0010808) | 1.98973231 |
135 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.98214560 |
136 | Ragged-red muscle fibers (HP:0003200) | 1.97570353 |
137 | Abnormality of the ischium (HP:0003174) | 1.97442825 |
138 | Short foot (HP:0001773) | 1.94547860 |
139 | Abnormality of the foot musculature (HP:0001436) | 1.94452443 |
140 | Dicarboxylic aciduria (HP:0003215) | 1.93793439 |
141 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.93793439 |
142 | Exercise intolerance (HP:0003546) | 1.93441082 |
143 | Abnormality of the pubic bones (HP:0003172) | 1.93353705 |
144 | Ketosis (HP:0001946) | 1.92941886 |
145 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.92876875 |
146 | Optic nerve hypoplasia (HP:0000609) | 1.92351940 |
147 | Limb-girdle muscle weakness (HP:0003325) | 1.91678147 |
148 | Large for gestational age (HP:0001520) | 1.91020339 |
149 | Progressive macrocephaly (HP:0004481) | 1.89207550 |
150 | Hemiparesis (HP:0001269) | 1.88660405 |
151 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.88613497 |
152 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.88485437 |
153 | Hypsarrhythmia (HP:0002521) | 1.88205429 |
154 | Facial hemangioma (HP:0000329) | 1.87425909 |
155 | Epileptiform EEG discharges (HP:0011182) | 1.87308443 |
156 | Mitochondrial inheritance (HP:0001427) | 1.87258765 |
157 | Foot dorsiflexor weakness (HP:0009027) | 1.85694963 |
158 | Type II lissencephaly (HP:0007260) | 1.85307393 |
159 | Vertebral arch anomaly (HP:0008438) | 1.84803584 |
160 | Polyphagia (HP:0002591) | 1.83468560 |
161 | Cerebral edema (HP:0002181) | 1.83392200 |
162 | Pheochromocytoma (HP:0002666) | 1.83260564 |
163 | Abnormality of the renal medulla (HP:0100957) | 1.83112833 |
164 | Chronic hepatic failure (HP:0100626) | 1.82978645 |
165 | Absent phalangeal crease (HP:0006109) | 1.82278056 |
166 | EEG with generalized epileptiform discharges (HP:0011198) | 1.80683309 |
167 | Calcaneovalgus deformity (HP:0001848) | 1.80211109 |
168 | Dyskinesia (HP:0100660) | 1.79877682 |
169 | Increased CSF lactate (HP:0002490) | 1.79405291 |
170 | Increased intramyocellular lipid droplets (HP:0012240) | 1.78537834 |
171 | Conjunctival hamartoma (HP:0100780) | 1.77798579 |
172 | Postaxial hand polydactyly (HP:0001162) | 1.77233830 |
173 | Adactyly (HP:0009776) | 1.77226598 |
174 | Broad ribs (HP:0000885) | 1.77055024 |
175 | Pachygyria (HP:0001302) | 1.76222076 |
176 | Postaxial foot polydactyly (HP:0001830) | 1.76022779 |
177 | Hyperalaninemia (HP:0003348) | 1.75292144 |
178 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.75292144 |
179 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.75252033 |
180 | Inability to walk (HP:0002540) | 1.75007583 |
181 | Hypoplastic ilia (HP:0000946) | 1.71462255 |
182 | Abnormality of salivation (HP:0100755) | 1.69515051 |
183 | Megalencephaly (HP:0001355) | 1.69481760 |
184 | 11 pairs of ribs (HP:0000878) | 1.69418955 |
185 | Genetic anticipation (HP:0003743) | 1.67380839 |
186 | Abnormality of the wing of the ilium (HP:0011867) | 1.65961032 |
187 | Abnormality of the corticospinal tract (HP:0002492) | 1.65641686 |
188 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.65524668 |
189 | Broad foot (HP:0001769) | 1.65480188 |
190 | Gaze-evoked nystagmus (HP:0000640) | 1.64475448 |
191 | Abnormal finger flexion creases (HP:0006143) | 1.64083385 |
192 | Abnormality of the antihelix (HP:0009738) | 1.63714299 |
193 | Lower limb muscle weakness (HP:0007340) | 1.63075753 |
194 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.63024879 |
195 | Gastrointestinal atresia (HP:0002589) | 1.61862723 |
196 | Ependymoma (HP:0002888) | 1.61828309 |
197 | Cutaneous finger syndactyly (HP:0010554) | 1.61226497 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 6.54740743 |
2 | TTN | 6.34137644 |
3 | PHKG1 | 4.60044346 |
4 | PHKG2 | 4.60044346 |
5 | EPHA4 | 3.57837339 |
6 | DMPK | 2.95382827 |
7 | PDK4 | 2.92041056 |
8 | PDK3 | 2.92041056 |
9 | MAPK15 | 2.87225745 |
10 | MARK1 | 2.82298752 |
11 | LMTK2 | 2.72667860 |
12 | FRK | 2.72453671 |
13 | MUSK | 2.59263212 |
14 | MYLK | 2.53735142 |
15 | TRIB3 | 2.47208512 |
16 | NEK1 | 2.46862708 |
17 | CASK | 2.39129822 |
18 | BCKDK | 2.36312496 |
19 | MAPK13 | 2.22448777 |
20 | PINK1 | 2.19384113 |
21 | PKN2 | 2.13285937 |
22 | PNCK | 2.12419342 |
23 | LATS1 | 1.98658898 |
24 | MAP2K3 | 1.95103115 |
25 | PIK3CA | 1.93425207 |
26 | NTRK3 | 1.93025326 |
27 | BCR | 1.81089817 |
28 | PDK2 | 1.78060223 |
29 | FGFR2 | 1.75081575 |
30 | WNK3 | 1.73072631 |
31 | MAP2K7 | 1.67237677 |
32 | TRIM28 | 1.59570099 |
33 | MAP4K2 | 1.59274569 |
34 | MAPKAPK3 | 1.57694197 |
35 | DAPK2 | 1.55019697 |
36 | UHMK1 | 1.54852452 |
37 | CDK19 | 1.52722963 |
38 | NME1 | 1.52139591 |
39 | PIK3CG | 1.47236881 |
40 | CDK3 | 1.46657516 |
41 | ERBB3 | 1.46358071 |
42 | MAP3K7 | 1.44068433 |
43 | TIE1 | 1.42787519 |
44 | MAPK12 | 1.39459187 |
45 | STK24 | 1.31920208 |
46 | NTRK2 | 1.31550529 |
47 | OXSR1 | 1.21448016 |
48 | CAMKK2 | 1.17541225 |
49 | PAK3 | 1.12353627 |
50 | DYRK2 | 1.08761451 |
51 | CAMK2D | 1.05326892 |
52 | MAP2K4 | 1.01400945 |
53 | PRKD1 | 0.97862075 |
54 | GRK7 | 0.96702488 |
55 | CSNK1G2 | 0.94385810 |
56 | CSNK1G1 | 0.94342381 |
57 | ILK | 0.91988719 |
58 | PRKAA1 | 0.89028920 |
59 | BRD4 | 0.88778970 |
60 | MAP3K5 | 0.88429303 |
61 | CAMK1G | 0.88005168 |
62 | PLK2 | 0.87627065 |
63 | SIK2 | 0.86143392 |
64 | PRKAA2 | 0.85685099 |
65 | MINK1 | 0.85233263 |
66 | TRPM7 | 0.85069848 |
67 | SGK223 | 0.83702237 |
68 | SGK494 | 0.83702237 |
69 | VRK1 | 0.83438049 |
70 | CSNK1A1L | 0.82344462 |
71 | MAP2K6 | 0.79987173 |
72 | RIPK1 | 0.79474012 |
73 | SGK2 | 0.79290302 |
74 | INSRR | 0.79089781 |
75 | WNK4 | 0.78262566 |
76 | CDK5 | 0.76910823 |
77 | PLK4 | 0.76852056 |
78 | ZAK | 0.76274448 |
79 | ROCK1 | 0.75556979 |
80 | CDC42BPA | 0.74714150 |
81 | STK11 | 0.74239724 |
82 | GRK1 | 0.73802492 |
83 | MAP3K3 | 0.72339794 |
84 | BMPR1B | 0.71119639 |
85 | NUAK1 | 0.69926509 |
86 | DYRK1A | 0.69844486 |
87 | CSNK1G3 | 0.67809800 |
88 | MAP3K6 | 0.67704025 |
89 | CAMKK1 | 0.65178457 |
90 | CDC7 | 0.64491982 |
91 | PKN1 | 0.60981304 |
92 | CAMK4 | 0.60422055 |
93 | FGFR1 | 0.59572926 |
94 | MARK2 | 0.59090241 |
95 | SIK3 | 0.58285173 |
96 | EEF2K | 0.56884564 |
97 | DYRK1B | 0.55476235 |
98 | PDGFRA | 0.54876602 |
99 | EPHB1 | 0.52948826 |
100 | EPHB2 | 0.51887479 |
101 | STK38 | 0.51769843 |
102 | BRSK2 | 0.51075109 |
103 | TNIK | 0.50211798 |
104 | CAMK2A | 0.48379145 |
105 | AKT2 | 0.47824893 |
106 | CCNB1 | 0.46969379 |
107 | CAMK2B | 0.46821531 |
108 | STK4 | 0.46768702 |
109 | CAMK2G | 0.44544201 |
110 | FLT3 | 0.44334478 |
111 | PRKCG | 0.43672710 |
112 | MKNK2 | 0.43436680 |
113 | GRK5 | 0.43228859 |
114 | CSNK1D | 0.42270177 |
115 | WNK1 | 0.42225689 |
116 | ADRBK1 | 0.41502006 |
117 | ROCK2 | 0.40928977 |
118 | PRKACB | 0.40804060 |
119 | CAMK1 | 0.40637200 |
120 | ADRBK2 | 0.40276582 |
121 | DAPK3 | 0.39888427 |
122 | KSR1 | 0.39820371 |
123 | PRKCZ | 0.39437198 |
124 | PRKACA | 0.38326470 |
125 | TGFBR2 | 0.37953632 |
126 | MAPK9 | 0.35675871 |
127 | PAK6 | 0.34950402 |
128 | FER | 0.33863876 |
129 | ICK | 0.33151690 |
130 | MAP3K1 | 0.31769583 |
131 | MAPK11 | 0.31742295 |
132 | PRKACG | 0.30540772 |
133 | MAP3K4 | 0.30506564 |
134 | TAOK1 | 0.30317899 |
135 | PRKCH | 0.29521934 |
136 | STK38L | 0.28889953 |
137 | RET | 0.28881646 |
138 | RPS6KC1 | 0.27822909 |
139 | RPS6KL1 | 0.27822909 |
140 | PDPK1 | 0.27644394 |
141 | MAP3K11 | 0.27259170 |
142 | PRKCE | 0.25969570 |
143 | SGK1 | 0.24135370 |
144 | SIK1 | 0.23775275 |
145 | PRKG1 | 0.23139513 |
146 | MAPK7 | 0.23136515 |
147 | PTK2B | 0.22910980 |
148 | PRKD3 | 0.21813299 |
149 | PTK6 | 0.21401800 |
150 | RPS6KA3 | 0.20854270 |
151 | KDR | 0.19724309 |
152 | PDK1 | 0.19445847 |
153 | RPS6KA1 | 0.19344705 |
154 | STK39 | 0.19196445 |
155 | MTOR | 0.19098151 |
156 | RPS6KA6 | 0.18909686 |
157 | KSR2 | 0.18113281 |
158 | NEK9 | 0.16077719 |
159 | MAP2K1 | 0.15692281 |
160 | RPS6KA2 | 0.15133363 |
161 | LATS2 | 0.12673590 |
162 | EPHA3 | 0.12431063 |
163 | PRKD2 | 0.11627193 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.64885343 |
2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.27712483 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.09164498 |
4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.70831201 |
5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.70608771 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.15498996 |
7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.10039288 |
8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.96368154 |
9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.88180956 |
10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.85897982 |
11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.72243250 |
12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.69850331 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.68974884 |
14 | Phototransduction_Homo sapiens_hsa04744 | 2.68344310 |
15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.49396252 |
16 | Cocaine addiction_Homo sapiens_hsa05030 | 2.43268174 |
17 | Carbon metabolism_Homo sapiens_hsa01200 | 2.33093505 |
18 | Alzheimers disease_Homo sapiens_hsa05010 | 2.28723359 |
19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.20988451 |
20 | Morphine addiction_Homo sapiens_hsa05032 | 2.07020962 |
21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.06835026 |
22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.05250877 |
23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.85576154 |
24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.78267219 |
25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.76348977 |
26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.70463429 |
27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64194085 |
28 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.61582631 |
29 | Axon guidance_Homo sapiens_hsa04360 | 1.56291956 |
30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.50965551 |
31 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.47519262 |
32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.45559005 |
33 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.37500551 |
34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.36413714 |
35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.35542588 |
36 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.32078099 |
37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.30846417 |
38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.29446263 |
39 | Insulin resistance_Homo sapiens_hsa04931 | 1.24824334 |
40 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.20456672 |
41 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.19800535 |
42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18749511 |
43 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.11617661 |
44 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.09767861 |
45 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.08173572 |
46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07887174 |
47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07675975 |
48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.07672950 |
49 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.06509731 |
50 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.04745238 |
51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.01688935 |
52 | Long-term depression_Homo sapiens_hsa04730 | 1.01002661 |
53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00812556 |
54 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.00400092 |
55 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.97464237 |
56 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.95925225 |
57 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.95773343 |
58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.95159490 |
59 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91966088 |
60 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.90192393 |
61 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88382504 |
62 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.84891156 |
63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84802888 |
64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82904853 |
65 | Basal transcription factors_Homo sapiens_hsa03022 | 0.82070600 |
66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.81851632 |
67 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.81800880 |
68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.80670444 |
69 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.79800636 |
70 | Lysine degradation_Homo sapiens_hsa00310 | 0.78426508 |
71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78105290 |
72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77920767 |
73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.77645082 |
74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76583753 |
75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75556729 |
76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74255304 |
77 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.74237709 |
78 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.74222075 |
79 | Insulin secretion_Homo sapiens_hsa04911 | 0.72141303 |
80 | Melanogenesis_Homo sapiens_hsa04916 | 0.72122467 |
81 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72021208 |
82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71628726 |
83 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70705389 |
84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70366467 |
85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64655842 |
86 | Tight junction_Homo sapiens_hsa04530 | 0.64322450 |
87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64044188 |
88 | Focal adhesion_Homo sapiens_hsa04510 | 0.63763044 |
89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63175451 |
90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62506561 |
91 | Renin secretion_Homo sapiens_hsa04924 | 0.58073932 |
92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57564745 |
93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56900053 |
94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56732850 |
95 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54472848 |
96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53631484 |
97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53106276 |
98 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.52205071 |
99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50798165 |
100 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50544789 |
101 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49753458 |
102 | Alcoholism_Homo sapiens_hsa05034 | 0.48938124 |
103 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.48176384 |
104 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47387297 |
105 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47295011 |
106 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.47109247 |
107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45772595 |
108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45747014 |
109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45622340 |
110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45424562 |
111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44803792 |
112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43685074 |
113 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43491746 |
114 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.43124474 |
115 | Peroxisome_Homo sapiens_hsa04146 | 0.43099130 |
116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42183368 |
117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40369272 |
118 | Circadian entrainment_Homo sapiens_hsa04713 | 0.39225201 |
119 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.35796080 |
120 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.28257177 |
121 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.27028429 |
122 | Amoebiasis_Homo sapiens_hsa05146 | 0.25753169 |
123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23972733 |
124 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23096711 |
125 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.22278437 |
126 | Adherens junction_Homo sapiens_hsa04520 | 0.21564386 |
127 | Gap junction_Homo sapiens_hsa04540 | 0.19745088 |
128 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.19183847 |
129 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.18882436 |
130 | Bile secretion_Homo sapiens_hsa04976 | 0.18223189 |
131 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.16763087 |
132 | Platelet activation_Homo sapiens_hsa04611 | 0.16348600 |
133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16249495 |
134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15450347 |
135 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.15278119 |
136 | ABC transporters_Homo sapiens_hsa02010 | 0.15263424 |
137 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.15151019 |
138 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.14148916 |
139 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.13467136 |
140 | Olfactory transduction_Homo sapiens_hsa04740 | 0.10816893 |
141 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.10552681 |
142 | Salivary secretion_Homo sapiens_hsa04970 | 0.10548629 |
143 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09220117 |
144 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.09215021 |
145 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08397353 |
146 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.07696774 |
147 | Taste transduction_Homo sapiens_hsa04742 | 0.07012018 |
148 | GABAergic synapse_Homo sapiens_hsa04727 | 0.06491578 |
149 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.06149308 |
150 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.05301256 |
151 | Long-term potentiation_Homo sapiens_hsa04720 | 0.05186819 |